SCOPUS 정보 검색 플랫폼

Volumn 22, Issue 3, 2016, Pages 279-280

Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation

(3) Carrion, Andres F a Khaderi, Saira A b Sussman, Norman L b

a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER (United States)

b BAYLOR COLLEGE OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD PUGH SCORE; DECOMPENSATED LIVER CIRRHOSIS; EDITORIAL; END STAGE LIVER DISEASE; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; HEPACIVIRUS;

END STAGE LIVER DISEASE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION;

EID: 84959368915 PISSN: 15276465 EISSN: 15276473 Source Type: Journal
DOI: 10.1002/lt.24383 Document Type: Editorial

Times cited : (34)

References (6)

1
- 84959337265
- Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis
- Modi AA, Nazario H, Trotter JF, Gautam M, Weinstein J, Mantry P, et al., Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis. Liver Transpl 2016; 22: 281-286.
- (2016) Liver Transpl , vol.22 , pp. 281-286
- Modi, A.A.¹ Nazario, H.² Trotter, J.F.³ Gautam, M.⁴ Weinstein, J.⁵ Mantry, P.⁶

2
- 84938953785
- Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease
- Charlton M, Everson GT, Flamm SL, Kumar P, Landis C, Brown RS Jr, et al., Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease. Gastroenterology 2015; 149: 649-659.
- (2015) Gastroenterology , vol.149 , pp. 649-659
- Charlton, M.¹ Everson, G.T.² Flamm, S.L.³ Kumar, P.⁴ Landis, C.⁵ Brown, R.S.⁶

3
- 84940793733
- Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies
- Deterding K, Höner Zu Siederdissen C, Port K, Solbach P, Sollik L, Kirschner J, et al., Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies. Aliment Pharmacol Ther 2015; 42: 889-901.
- (2015) Aliment Pharmacol Ther , vol.42 , pp. 889-901
- Deterding, K.¹ Höner Zu Siederdissen, C.² Port, K.³ Solbach, P.⁴ Sollik, L.⁵ Kirschner, J.⁶

4
- 79957497436
- A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C
- Backus LI, Boothroyd DB, Phillips BR, Belperio P, Halloran J, Mole LA,. A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C. Clin Gastroenterol Hepatol 2011; 9: 509-516.
- (2011) Clin Gastroenterol Hepatol , vol.9 , pp. 509-516
- Backus, L.I.¹ Boothroyd, D.B.² Phillips, B.R.³ Belperio, P.⁴ Halloran, J.⁵ Mole, L.A.⁶

5
- 84871487025
- Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis
- van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, et al., Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012; 308: 2584-2593.
- (2012) JAMA , vol.308 , pp. 2584-2593
- Van Der Meer, A.J.¹ Veldt, B.J.² Feld, J.J.³ Wedemeyer, H.⁴ Dufour, J.F.⁵ Lammert, F.⁶

6
- 84943579941
- Current management of hepatitis C virus: Regimens for peri-liver transplant patients
- Saxena V, Terrault N,. Current management of hepatitis C virus: regimens for peri-liver transplant patients. Clin Liver Dis 2015; 19: 669-688.
- (2015) Clin Liver Dis , vol.19 , pp. 669-688
- Saxena, V.¹ Terrault, N.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.